Xiaoming Zhang
- Immunology top 2%
- T-cell and B-cell Immunology 17
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 12
- Reproductive System and Pregnancy 7
- Immune Response and Inflammation 5
- Hepatology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Cancer Research top 10%
- Epidemiology top 5%
-
- Systemic Lupus Erythematosus Research 5
-
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Richard Lo‐ManDania ZhivakiQiang GaoJiaqiang MaShyamal GoswamiHailei WangDongbo ZhouBingyu Sun
- Cited by
- ImmunologyHepatologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Advanced Materials (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaoming Zhang
80 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 150
- Immunology 1.3k
- Hepatology 190
- Oncology 569
- Cancer Research 243
- Epidemiology 487
Countries citing papers authored by Xiaoming Zhang
This map shows the geographic impact of Xiaoming Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Zhang more than expected).
Fields of papers citing papers by Xiaoming Zhang
This network shows the impact of papers produced by Xiaoming Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Zhang. The network helps show where Xiaoming Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoming Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 33 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 144 | |
| 13 | 2020 | 29 | |
| 14 | 2020 | 37 | |
| 15 | 2020 | 17 | |
| 16 | 2019 | 114 | |
| 17 | 2019 | 36 | |
| 18 | 2019 | 29 | |
| 19 | 2014 | 2 | |
| 20 | 2007 | 118 |
About Xiaoming Zhang
Xiaoming Zhang is a scholar working on Immunology, Hepatology and Gastroenterology, having authored 86 papers that have together received 3.0k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (17 papers), Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), Reproductive System and Pregnancy (7 papers), Systemic Lupus Erythematosus Research (5 papers), Immune Response and Inflammation (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Immunology (1.3k citations), Hepatology (190 citations) and Oncology (569 citations). Xiaoming Zhang has collaborated with scholars based in China, United States and France. Frequent co-authors include Richard Lo‐Man, Dania Zhivaki, Qiang Gao, Jiaqiang Ma, Shyamal Goswami, Hailei Wang, Dongbo Zhou, Bingyu Sun, Feng Ling and Wenbo Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.